Moderna sues Pfizer/BioNTech over COVID vaccine

Pfizer/BioNTech

Moderna sues Pfizer/BioNTech for alleged patent infringement on COVID vaccine
Moderna Inc and the Pfizer Inc and BioNTech partnership were two of the first groups to develop a COVID vaccine when the pandemic began.

Moderna is suing Pfizer and its German partner BioNTech for alleged patent infringement in the development of the first approved COVID-19 vaccine in the US.

The lawsuit, seeking unspecified monetary damages, alleges that they copied technology that Moderna had developed years before the pandemic.

Moderna CEO Stephane Bancel said, “We brought these lawsuits to protect the groundbreaking mRNA technology platform that we pioneered, spent billions of dollars creating, and patented over the decade before the COVID pandemic. -19”. “Pfizer and BioNTech, however, ultimately decided to proceed with a vaccine that has the exact same mRNA chemical modification as their vaccine.”

Bancel said the company continues to use the technology to develop treatments for influenza and HIV, as well as autoimmune and cardiovascular diseases and rare forms of cancer.

“We believe that Pfizer and BioNTech illegally copied Moderna’s inventions and have continued to use them without permission,” Moderna Chief Legal Officer Shannon Thyme Klinger added.

Moderna Inc and the partnership of Pfizer Inc and BioNTech were two of the first groups to develop a vaccine for COVID.

Just a decade old, Moderna had been an innovator in messenger RNA (mRNA) vaccine technology, which works by teaching human cells how to make a protein that will trigger an immune response.

The technology helped speed up the approval process for injections, which typically takes years to complete, and allowed the vaccine to be developed so quickly.

Germany-based BioNTech had also been working in this field when it partnered with US pharmaceutical giant Pfizer.

The US Food and Drug Administration Pfizer/BioNTech granted emergency use authorization for first time the association’s vaccine.


Leave a Reply

Your email address will not be published. Required fields are marked *